USFDA inspection at Piramal Pharma’s Bethlehem facility

IIM Kashipur inks MoU with Max Healthcare to launch PG Diploma Programme in Hospital Management

Ajanta Pharma receives USFDA for Topiramate Extended Release Capsules

Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR

Apollo’s Apollo Connect program bets big on expanding access and elevating care

Aims to build the largest connected healthcare ecosystem in India

Gland Pharma receives 2 observations under 483 for Pashamylaram facility

The company is committed to address the observations and will submit its response to US FDA within the stipulated time

Dr Srikanth Ramaswamy bags Lister Prize to fund brain research

Newcastle University’s Dr Srikanth Ramaswamy has been announced as one of six new Fellows selected for the 2023 Lister prize

Govt. of Arunachal, Sir Ganga Ram Hospital and Religare Enterprises sign an MoU to support the development of the state’s healthcare services

The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)

Yashoda Medicity, Indirapuram and Draeger India join hands to establish modular ICU setup

Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes

Piramal Pharma posts Q1 FY24 consolidated loss at Rs. 98.58 Cr

The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023

Riparian Pharmaceuticals inks license and research agreement with Pfizer for cardiovascular programs

Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics